Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Admixture-matched case-control study: a practical approach for genetic association studies in admixed populations.
Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells.
Predictors of criminal justice involvement in severe mania.
Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1.
Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.
See All 19 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.
Padma V, Fisher M, Moonis M. Thrombolytic therapy for acute ischemic stroke: 3 h and beyond. Expert Rev Neurother. 2005 Mar; 5(2):223-33.
View in:
PubMed
subject areas
Acute Disease
Animals
Diffusion Magnetic Resonance Imaging
Drug Therapy, Combination
Expert Testimony
Fibrinolytic Agents
Humans
Injections, Intravenous
Meta-Analysis as Topic
Neuroprotective Agents
Platelet Glycoprotein GPIIb-IIIa Complex
Streptokinase
Stroke
Thrombolytic Therapy
Time Factors
Tissue Plasminogen Activator
authors with profiles
Majaz Moonis MD